AMGN vs CPIX · P/E 24, rev $36.75B vs rev $10.4M
Amgen Inc (AMGN) versus Cumberland Pharmaceuticals Inc (CPIX) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CPIX currently screens at market cap $86.9M.
Not investment advice. Open the AMGN and CPIX stock pages for the full models.
Not investment advice.